NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Psyence Biomedical’s Texas subsidiary has signed a binding term sheet giving it exclusive US rights to supply and distribute PsyLabs’ pharmaceutical-grade ibogaine.
Texas Ibogaine Research Corporation will receive exclusive US rights to PsyLabs’ ibogaine know-how, supply and wholesale distribution, while PsyLabs retains rights elsewhere. The arrangement includes up to approximate...
Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics
This systematic review and meta-analysis (s=61) examined immune changes after serotonergic psychedelics in laboratory, animal and human studies. Most laboratory and animal studies found reduced inflammation, including...
Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics
This systematic review and meta-analysis (s=61) examined immune changes after serotonergic psychedelics in laboratory, animal and human studies. Most laboratory and animal studies found reduced inflammation, including...
Benuvia Operations, LLC has applied to register as an importer of basic classes of controlled substances.
Benuvia Operations, LLC has applied to be registered as an importer of basic classes of controlled substances. The application refers to supplementary information for further drug details.
Spiral brain dynamics track the temporal unfolding of subjective intensity during the N,N-dimethyltryptamine experience
This preprint reanalysed placebo-controlled DMT fMRI data from healthy volunteers (n=17 for the main analyses; n=14 for time-resolved analyses). DMT increased spiral vorticity and its spatial dispersion and reduced te...
Federal drug enforcement revives proposal to place five hallucinogens in Schedule I category; Oregon reverses planned fee increase for psilocybin licensees
Plus: California passes bill including $4.7 million for psychedelic research; How should the lasting effects of psychedelics be measured?
Humans Have Been Using Drugs for at Least 25,000 Years
Drug use isn’t a modern cultural glitch. It’s part of the human story.
1967 guide for LSD use still relevant as psychedelics gain in popularity
As psychedelic drugs such as LSD gain new momentum as treatments for severe post-traumatic stress disorder (PTSD), depression and even headaches, a University at Buffalo researcher is exploring safety education for re...
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Q2 2026 Federal Psychedelic Lobbying Update Now that federal lobbying data from the second quarter of the year is available to retrieve, we present our regular update on the state of activity across psychedelic drug d...
Clay Martin and the Path of the Barbarian Spirit
The psychedelic landscape in 2026 is a lot weirder than you might think
Ketamine-enhanced psychotherapy for smoking cessation: A pilot study of feasibility, safety, and clinical outcomes
This open-label pilot study (n=7) assessed three weekly intramuscular ketamine sessions (50 mg/70 kg) combined with motivational enhancement therapy for smoking cessation. All participants completed treatment, which w...
Subacute effects of ketamine on neural correlates of reward processing
This single-blind, placebo-controlled crossover study (n=28) found that a 0.5 mg/kg ketamine infusion did not significantly alter brain responses during a reward task when measured 5 hours later in healthy participant...
Ketamine-enhanced psychotherapy for smoking cessation: A pilot study of feasibility, safety, and clinical outcomes
This open-label pilot study (n=7) assessed three weekly intramuscular ketamine sessions (50 mg/70 kg) combined with motivational enhancement therapy for smoking cessation. All participants completed treatment, which w...
Subacute effects of ketamine on neural correlates of reward processing
This single-blind, placebo-controlled crossover study (n=28) found that a 0.5 mg/kg ketamine infusion did not significantly alter brain responses during a reward task when measured 5 hours later in healthy participant...
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), today announced its licensee – Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"),…